1. Home
  2. SEPN vs HCI Comparison

SEPN vs HCI Comparison

Compare SEPN & HCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEPN
  • HCI
  • Stock Information
  • Founded
  • SEPN 2022
  • HCI 2006
  • Country
  • SEPN United States
  • HCI United States
  • Employees
  • SEPN N/A
  • HCI N/A
  • Industry
  • SEPN
  • HCI Property-Casualty Insurers
  • Sector
  • SEPN
  • HCI Finance
  • Exchange
  • SEPN NYSE
  • HCI Nasdaq
  • Market Cap
  • SEPN 1.0B
  • HCI 1.2B
  • IPO Year
  • SEPN 2024
  • HCI N/A
  • Fundamental
  • Price
  • SEPN $23.30
  • HCI $109.73
  • Analyst Decision
  • SEPN Strong Buy
  • HCI Buy
  • Analyst Count
  • SEPN 4
  • HCI 5
  • Target Price
  • SEPN $43.67
  • HCI $140.00
  • AVG Volume (30 Days)
  • SEPN 237.6K
  • HCI 123.8K
  • Earning Date
  • SEPN 02-15-2025
  • HCI 11-07-2024
  • Dividend Yield
  • SEPN N/A
  • HCI 1.45%
  • EPS Growth
  • SEPN N/A
  • HCI 163.93
  • EPS
  • SEPN N/A
  • HCI 11.94
  • Revenue
  • SEPN $981,000.00
  • HCI $750,846,000.00
  • Revenue This Year
  • SEPN N/A
  • HCI N/A
  • Revenue Next Year
  • SEPN N/A
  • HCI $7.38
  • P/E Ratio
  • SEPN N/A
  • HCI $9.14
  • Revenue Growth
  • SEPN N/A
  • HCI 48.73
  • 52 Week Low
  • SEPN $18.62
  • HCI $81.35
  • 52 Week High
  • SEPN $27.47
  • HCI $126.50
  • Technical
  • Relative Strength Index (RSI)
  • SEPN N/A
  • HCI 47.83
  • Support Level
  • SEPN N/A
  • HCI $110.02
  • Resistance Level
  • SEPN N/A
  • HCI $116.18
  • Average True Range (ATR)
  • SEPN 0.00
  • HCI 3.90
  • MACD
  • SEPN 0.00
  • HCI -0.59
  • Stochastic Oscillator
  • SEPN 0.00
  • HCI 20.39

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR.

About HCI HCI Group Inc.

HCI Group Inc is engaged in the property and casualty insurance business through two Florida domiciled insurance companies, Homeowners Choice Property & Casualty Insurance Company (HCPCI) and TypTap Insurance Company (TypTap). Both HCPCI and TypTap are authorized to underwrite various homeowners' property and casualty insurance products and allied lines business in the state of Florida and other states. The operating segments of the group are HCPCI insurance operations, TypTap Group, Real estate operations, and Corporate and other. It derives key revenue from the HCPCI Insurance operation segment.

Share on Social Networks: